Skip to main content
2025 SCMR Conference Main banner
Final Program


Schedule at a Glance
Back

John Greenwood, MBChB, PhD, FRCP, FSCMR, FACC, FESC, FBCS, FICS

Professor/Director
Baker Heart and Diabetes Institute
Melbourne University, Australia

John Greenwood is Director of the Baker Heart and Diabetes Institute, Melbourne, Australia and Adjunct/Visiting Professor of Cardiology at University Melbourne, Monash University, Australia and also the University of Leeds, UK.

As a consultant cardiologist he specialised in coronary intervention and cardiovascular magnetic resonance (CMR) imaging. His main area of research is the diagnosis and treatment of stable and unstable coronary artery disease. In terms of diagnostics, this particularly involved the use of CMR in terms of its development and validation through clinical trials. In terms of therapeutics, he has collaborated on a number of major multi-centre clinical trials designed to improve outcomes in patients undergoing primary PCI for acute ST elevation myocardial infarction or stable complex coronary artery disease.

He was President of the British Cardiovascular Society (BCS; 2021-2024) and a member of Council of The Royal College of Physicians, London (2021-2024). He was elected to the Board of BSCMR (British Society of Cardiovascular MR) in 2008 and became Treasurer and then BSCMR President (2018-2020).

He is past-Chair of the SCMR clinical trials committee (2015-2017) and member of the SCMR scientific programme committee (2016-2019). He was the SCMR representative on the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain. He was a winner of the SCMR Gold Medal in 2023, Associate Editor of JCMR (2017-2023) and elected to the SCMR Board of Trustees in the position of Non-US Cardiologist (2025). He was a member of the ESC Cardio-policy group (2022-2024), ESC Advocacy Committee (2021-2024) and a member of the Assembly of International Governors of the ACC (2021-2024).

Presentation(s):